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This is an opinion based on the paper
“Cloning of cDNA encoding the murine
IgG1 induction factor by a novel strategy
using SP6 promoter” (1).
The mechanism by which B cells can
produce classes other than IgM and IgD has
interested me since the middle of the 1970s.
It was initially not clear that B cells could
produce more than one Ig class, whereas
we now know that they first produce IgM
and IgD and then – after activation – they
can switch to produce IgG, IgA, or IgE.
Interleukin 4 (IL-4) can regulate Ig class
switching in mice to IgG1 and IgE, and in
humans to some subclasses of IgG and to
IgE. Other cytokines can induce activation
of various Ig classes and subclasses. Below
is a personal tale of how I became involved
in the molecular cloning of IL-4.
When I was a PhD student in the begin-
ning of the 1970s, many of us at the
Department of Immunobiology, Karolin-
ska Institutet were intrigued by the ques-
tion of whether, and if so how, B-cells
switched Ig class. In the laboratory, Göran
and Erna Möller and their groups were
studying in vitro responses to T and B-cell
mitogens, using mouse spleen cells. While
stimulation with T cell-dependent antigens
in vivo led to IgM and IgG responses, T
cell-independent antigens did not induce
an IgG response. Likewise, B-cell mitogens
in vitro gave rise only to an IgM response.
Since, we were concerned that fetal calf
serum contained mitogenic substances;
we used serum-free cultures. However, in
order to obtain any response at all, we had
to culture cells very densely. Kearny and
Lawton then published a paper, describing
the low-cell-density culture system (2). By
culturing spleen cells at much lower cell
densities, and by including fetal calf serum
and 2-mercaptoethanol together with the
mitogen lipopolysaccharide (LPS), B cells
were induced to produce both IgM and
IgG. This was an important discovery, since
it was the first time IgG production had
been induced in vitro. We tried to repro-
duce the experiment, but we had no good
way to measure a polyclonal IgG response.
At that time, we measured IgM responses
in a plaque assay, using haptenated sheep
erythrocytes, but it was not suitable for
measuring IgG responses. Kearny and Law-
ton had used intracellular fluorescence in
a UV microscope to detect IgG-producing
cells, but we wanted a more quantitative
assay. The idea occurred to me to develop
an assay using protein A. It binds IgG and
thus, by coating it to sheep erythrocytes, we
might be able to develop a plaque assay for
IgG-secreting cells. Antonio Coutinho and
I decided to try the idea, so I went to visit
him at Basel Institute for Immunology in
Switzerland, where he worked as a postdoc.
He thawed different mouse plasmacytomas
that Fritz Melchers had in his lab. We could
also use rabbit antisera to different mouse
Ig isotypes, also from Fritz’s lab. I came
to Basel in January 1976 and, if I remem-
ber correctly, the experiment worked first
time. However, there were no plaques in
the absence of developing antisera, as I had
predicted. A likely explanation is that the
rabbit IgG antisera bound the protein A
and thus formed a bridge between protein
A and the secreted Ig. This meant that we
could detect any class of Ig from secreting
cells if we just had a suitable antiserum. We
worked day and night for 6 weeks to fur-
ther develop the technique. More than once
I met Susumi Tonegawa at the soft-drinks
machine at night. He was then finishing his
ground-breaking work on the movement
of Ig V genes in B cell-development. A few
months later, he presented his results at a
Cold Spring Harbor meeting and I was in
the audience. That was a very memorable
moment. I left for the US 6 weeks later,
and Antonio and Fritz finished the paper
about the protein A plaque assay (3). Now,
there was a good and convenient method
to detect IgG-secreting cells.
I started as a postdoc in Sam Strober’s
lab in Department of Medicine, at Stanford
University Medical Center, in February
1976. Upstairs from his lab, in Len and Lee
Herzenberg’s group at the Department of
Genetics, there was intense research using
one the first flow cytometry machines. I
wished to determine if the IgG response
obtained after LPS stimulation in vitro was
derived from IgM-producing cells, i.e., if
there was a true switching event occur-
ring in the cultures. I sorted IgM and IgG
positive and negative cells and cultured
the populations separately, and could show
that the IgG-producing cells came from
IgM+, IgG− precursors (4). One curious
observation was that the main IgG sub-
classes produced were IgG2b and IgG3, and
we did not detect very much IgG1,although
the latter is the dominant subclass in serum.
Back in Stockholm a few years later, I
read a manuscript by Peter Isakson et al.
in Ellen Vitetta’s lab about a factor that
induced an elevated IgG response, mostly
of the IgG1 subclass, when given to LPS cul-
tures. Their paper was published in 1982
in J Exp Med (5), in the same issue as a
paper by Maureen Howard et al. in Bill
Paul’s group about a factor that induced
DNA synthesis in B cells together with
anti-IgM (6). These two papers are to
my knowledge the first to describe the
function of what later became known as
interleukin 4 (IL-4). Peter used super-
natants from different T cell lines. We
tested supernatants from primary mixed
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lymphocyte cultures that we obtained from
Antonio Coutinho and they worked in
a similar way, the elevated IgG being
mostly IgG1. We were Susanne Bergstedt-
Lindqvist, Paschalis Sideras, both PhD stu-
dents and myself. Although they worked
with me, neither were officially my stu-
dents, because I only had a very small grant
at the time.
It became clear that the stimuli dictated
the subclass produced by B cells. The T-
independent LPS gave rise to IgG2b and
IgG3, but addition of factors produced by T
cells caused B cells to produce IgG1 instead.
We realized eventually that we needed
a more reliable source of the IgG1 induc-
tion factor, which was the name we gave it.
For this reason, Paschalis and I and went to
Lausanne to work in Marcus Nabholz’s lab
at ISREC (Swiss Institute for Experimental
Research). This was in the spring of 1983. In
the neighboring lab Rob MacDonald and
his group were working with continuous T
cell lines from primary cultures. From the
very back of the incubator, we retrieved a
flask that appeared to have been forgotten.
We re-stimulated the cells, cloned them and
tested the supernatants for IgG1-inducing
activity. There were several clones that were
positive. Rob suggested later that the fact
that the flask had been forgotten might
have increased the chances to select for IL-4
secreting cells, due to autocrine activation.
Usually, cells were re-stimulated with irra-
diated stimulatory cells plus IL-2, which
most would probably have repressed IL-4
production.
We took the T cell clones with us back
to Stockholm and decided to characterize
the IgG1 induction factor in biochemical
terms. For this, we developed a quantita-
tive assay, using serial dilutions of the factor
in cultures. We obtained this idea from
Kendall Smith’s work with IL-2. We had
met Ken at conferences and he was always
very supportive of our work. We wrote a
paper describing the different T cell clones,
one of them being the 2.19 cell line, which
we used later on to clone IL-4 (7). Another
paper of ours described the biochemical
characteristics of the IgG1 induction factor,
which indicated that our factor had proper-
ties similar to Paul’s B-cell-stimulating fac-
tor (8). When Paschalis showed our data at
a Keystone meeting, it did not attract very
much attention. The general idea at the
time was that each function was regulated
by distinct factors and thus it was con-
sidered very unlikely that the same factor
would induce proliferation together with
anti-IgM and an elevated IgG1 response
together with LPS.
In August 1983, I went to the Congress
of Immunology in Kyoto. It was terribly
hot and I was 7 months pregnant. The most
exciting talks were those by Ellis Reinherz,
Mark Davis, and James Allison, describ-
ing for the first time the T cell receptor.
Also, I remember several people being very
upset with the scientists who had claimed
that T cells expressed immunoglobulin.
That hypothesis died completely at this
conference.
In connection with this meeting I vis-
ited Tasuku Honjo, who was then working
at Osaka University. I had met him twice
before in Sweden. He was well known for
having correctly determined the gene order
of the heavy-chain C gene segments in mice
and for discovering the heavy-chain switch
regions (9). I gave a seminar about our
preliminary data with the IgG1 induction
factor. Tasuku suggested collaboration: “I
would like to clone switch factors” he said.
Back in Sweden in December of 1983, I gave
birth to my first child, John.
To attempt to clone the IgG1 induc-
tion factor without having purified it or
a specific antibody was a bold attempt,
which I had thought would not be within
my reach. Tasuku, being a careful person
and probably a bit suspicious of the cel-
lular techniques, wanted first to test our
assay to measure the response. So we sent
him the protocol together with the nec-
essary ingredients and they obtained the
same response as we did. Paschalis and
Susanne then started to collect 109 cells of
the 2.19 cell line to send to Honjo’s group.
This took several months, since these were
primary T cells stimulated by irradiated
allogeneic spleen cells and they grew rather
slowly. The final stimulation was done with
concanavalin A (ConA). We sent the cells
by the end of June 1984 and people in
Honjo’s group prepared mRNA. A second
batch of cells was sent later. At this time,
we also received a lot of help from Lena
Berggren (now Lena Ström), our techni-
cian. She eventually got a PhD with me
as her supervisor and is now an estab-
lished scientist working with genome sta-
bility and variation. Honjo’s group puri-
fied mRNA and as a first test, injected it
into Xenopus oocytes and collected super-
natants. The supernatants indeed gave an
increased IgG1 response when given to LPS
cultures. This result was obtained in Octo-
ber 1984. Then, Honjo’s coworkers trans-
fected COS cells with a cDNA library from
the 2.19 mRNA, took supernatants and sent
them to us in Sweden. However, COS cell
supernatants were inhibitory when given to
LPS cultures, perhaps due to mycoplasma-
infection, since this notoriously inhibits B
cell activation in vitro. Tasuku was com-
pelled to change strategy, and came up with
a very ingenious one: They constructed an
Sp6 expression vector and cloned cDNA
out of 2.19 mRNA, did in vitro transcrip-
tion, and injected the RNA into oocytes.
The oocyte supernatants were then sent to
us for testing. This strategy worked well and
we could detect IgG1-inducing activity for
as many as 45,000 mixed clones. The num-
bers of clones per batch decreased for each
round of testing, until we finally had single
positive clones. We reached single clones
in the summer of 1985. The cDNA from a
positive clone was sequenced and found to
encode a protein of MW around 15,000. It
had some homologies suggesting a distant
relation to γ interferon (γIFN) and granu-
locyte macrophage colony-stimulating fac-
tor (GM-CSF). We tested the recombi-
nant supernatant and found that it induced
higher MCH class II levels and increased
DNA synthesis when given together with
anti-IgM. We concluded that the IgG1
induction factor and the B-cell-stimulating
factor-1 (BSF-1) were products of the same
gene. First, we wrote two papers (letters)
that we submitted to Nature. One, for
whichYoshihiko Noma was first author and
Tasuku was senior author, dealt with the
molecular cloning. The other, for which
Paschalis was first author and I was senior
author, was about the function of the
cloned factor on B cell responses. The edi-
tors of Nature wished us to merge the two
papers and invited us to write an article
instead. This we did, and the paper was
published in February 1986 (1). In April the
same year, Lee et al. published a paper iden-
tifying the same cytokine, also by cDNA
cloning. The cytokine could activate T and
B cells, as well as mast cells. It acted as
a B-cell-stimulating factor, and induced
IgG1 and IgE (10). At the end of both of
the papers, we proposed that the cytokine
should be called“interleukin-4.”Our paper
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attracted a lot of attention, partly because
the cloning method was unique. It should
be pointed out that cDNA cloning at this
time was not a technique that any lab could
do. In fact, only a few groups in the world
mastered it, and Honjo’s lab was one of the
best. Secondly, the two papers revealed that
IL-4 was very pleiotropic, having effects on
at least three cell types and inducing dif-
ferent responses in B cells, as opposed to
other known cytokines, and quite differ-
ent from the idea that one cytokine would
only activate a single response. The molec-
ular cloning of IL-4 inspired a great deal of
further research. In August the same year,
a paper was published about cloning of
the cDNA that encoded human IL-4 (11).
Soon it became apparent that both human
and mouse IL-4 induced an IgE response
(10, 12) and it was subsequently showed,
using the knockout technology, that IL-
4 is essential for IgE expression in mice
(13). Thus, IL-4 was found to be clinically
relevant for understanding the induction
of atopic allergy. Furthermore, the finding
that IL-4 is secreted by a subpopulation of
T helper cells, called TH2 (14), inspired a
flood of research in humans. In the field
of Ig class switching, IL-4 is still one of the
model stimuli in research of class switch
recombination in the mouse, because of
its efficient induction of IgG1 and because
the discovery that stimuli direct switch-
ing by inducing germ-line transcripts (15,
16). Many cytokines have been described
since then: a glance at internet reveal the
existence of IL-38.
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